Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Change of treatment from cyclosporin to mycophenolate mofetil in severe psoriasis.

Davison SC, Morris-Jones R, Powles AV, Fry L.

Br J Dermatol. 2000 Aug;143(2):405-7.

PMID:
10951153
2.

Sequential study on the treatment of moderate-to-severe chronic plaque psoriasis with mycophenolate mofetil and cyclosporin.

Pedraz J, Daudén E, Delgado-Jiménez Y, García-Río I, García-Díez A.

J Eur Acad Dermatol Venereol. 2006 Jul;20(6):702-6.

PMID:
16836499
3.

Combined mycophenolate mofetil and cyclosporin therapy for severe recalcitrant psoriasis.

Ameen M, Smith HR, Barker JN.

Clin Exp Dermatol. 2001 Sep;26(6):480-3.

PMID:
11678869
4.

Mycophenolate mofetil as a systemic antipsoriatic agent: positive experience in 11 patients.

Geilen CC, Arnold M, Orfanos CE.

Br J Dermatol. 2001 Mar;144(3):583-6.

PMID:
11260019
5.

Psoriasis vulgaris treated successfully with mycophenolate mofetil.

Haufs MG, Beissert S, Grabbe S, Schütte B, Luger TA.

Br J Dermatol. 1998 Jan;138(1):179-81.

PMID:
9536244
6.

Long-term safety of mycophenolate mofetil and cyclosporine: a review.

Buell C, Koo J.

J Drugs Dermatol. 2008 Aug;7(8):741-8. Review.

PMID:
18720690
7.

Plasma trough levels of mycophenolic acid do not correlate with efficacy and safety of mycophenolate mofetil in psoriasis.

Daudén E, Sánchez-Peinado C, Ruiz-Genao D, García-F-Villalta M, Onate MJ, García-Díez A.

Br J Dermatol. 2004 Jan;150(1):132-5.

PMID:
14746627
8.

A comparison of mycophenolate mofetil with ciclosporine for the treatment of chronic plaque-type psoriasis.

Beissert S, Pauser S, Sticherling M, Frieling U, Loske KD, Frosch PJ, Haase I, Luger TA.

Dermatology. 2009;219(2):126-32. doi: 10.1159/000226134. Epub 2009 Jun 23.

PMID:
19546522
9.

Mycophenolate mofetil substitution for cyclosporine-dependent myasthenia gravis and nephrotoxicity.

Lim AK, Donnan G, Chambers B, Ierino FL.

Intern Med J. 2007 Jan;37(1):55-9.

PMID:
17199845
10.

Renal function after 10 years' treatment with cyclosporin for psoriasis.

Powles AV, Hardman CM, Porter WM, Cook T, Hulme B, Fry L.

Br J Dermatol. 1998 Mar;138(3):443-9.

PMID:
9580797
11.

Mycophenolate mofetil, an alternative to cyclosporine A for long-term immunosuppression in kidney transplantation?

Houde I, Isenring P, Boucher D, Noël R, Lachanche JG.

Transplantation. 2000 Oct 27;70(8):1251-3.

PMID:
11063351
12.

Treatment of chronic plaque-stage psoriasis and psoriatic arthritis with mycophenolate mofetil.

Grundmann-Kollmann M, Mooser G, Schraeder P, Zollner T, Kaskel P, Ochsendorf F, Boehncke WH, Kerscher M, Kaufmann R, Peter RU.

J Am Acad Dermatol. 2000 May;42(5 Pt 1):835-7.

PMID:
10775866
13.

Mycophenolate mofetil (CellCept) for psoriasis: a two-center, prospective, open-label clinical trial.

Zhou Y, Rosenthal D, Dutz J, Ho V.

J Cutan Med Surg. 2003 May-Jun;7(3):193-7.

PMID:
12704533
14.

Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial.

Reitamo S, Spuls P, Sassolas B, Lahfa M, Claudy A, Griffiths CE; Sirolimus European Psoriasis Study Group.

Br J Dermatol. 2001 Sep;145(3):438-45.

PMID:
11531834
15.

Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses.

Kitchin JE, Pomeranz MK, Pak G, Washenik K, Shupack JL.

J Am Acad Dermatol. 1997 Sep;37(3 Pt 1):445-9. Review.

PMID:
9308561
16.

Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation.

Lau CH, Comer M, Lightman S.

Clin Exp Ophthalmol. 2003 Dec;31(6):487-91.

PMID:
14641155
17.

Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.

Johnson C, Ahsan N, Gonwa T, Halloran P, Stegall M, Hardy M, Metzger R, Shield C 3rd, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M, van Veldhuisen P, Salm K, Tolzman D, Fitzsimmons WE.

Transplantation. 2000 Mar 15;69(5):834-41.

PMID:
10755536
18.

Mycophenolate mofetil-based, cyclosporine-free induction and maintenance immunosuppression: first-3-months analysis of efficacy and safety in two cohorts of renal allograft recipients.

Zanker B, Schneeberger H, Rothenpieler U, Hillebrand G, Illner WD, Theodorakis I, Stangl M, Land W.

Transplantation. 1998 Jul 15;66(1):44-9.

PMID:
9679820
19.

[Mycophenolate mofetil: a new immunosuppressive drug in dermatology and its possible uses].

Geilen CC, Orfanos-Boeckel H, Offermann G, Orfanos CE.

Hautarzt. 2000 Feb;51(2):63-9. Review. German.

PMID:
10743574
20.

Mycophenolate mofetil in cyclosporin-associated thrombotic microangiopathy.

Lecornu-Heuze L, Ducloux D, Rebibou JM, Martin L, Billerey C, Chalopin JM.

Nephrol Dial Transplant. 1998 Dec;13(12):3212-3. No abstract available.

PMID:
9870494

Supplemental Content

Support Center